Why Is Cogent Biosciences Stock (COGT) Up 115% Today?

tipranks.com/news/why-is-cogent-biosciences-stock-cogt-up-115-today

stock surged on Monday after the biotechnology company announced positive results from its Phase 3 PEAK trial of bezuclastinib combined with sunitinib in patients with imatinib-resistant or intolerant gastrointestinal stromal tumors (GIST).
Meet Your ETF AI Analyst
- Discover how…

This story appeared on tipranks.com, 2025-11-10 18:04:42.628000.
The Entire Business World on a Single Page. Free to Use →